Latest News
US FDA grants orphan drug designation for Lundbeck's asedebart
11 September 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B), which focuses on brain health, said on Friday it has received US Food and Drug Administration orphan drug designation for asedebart (Lu AG13909), its investigational ...
ABL Diagnostics files bid to acquire IntegraGen
11 September 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Friday that it has filed a bid to acquire the business operations and assets of IntegraGen, a company specialising in genomic analysis of n...
ABEC opens new manufacturing facility in Wilson, NC
11 September 2026 - ABEC, a provider of customised solutions and services for biopharmaceutical manufacturing, on Thursday announced the grand opening of its newest manufacturing facility in Wilson, North Carolina.An official ribbon-cutting ceremony ...
AbbVie declares quarterly dividend of USD1.73 per share
11 September 2026 - US pharmaceutical company AbbVie (NYSE:ABBV) announced on Thursday that its board of directors has declared a quarterly cash dividend of USD1.73 per share.This amount is unchanged from the previous quarterly dividend.Stockholders ...
Renova Pharmaceuticals launches first three US generic products
11 September 2026 - Generic medicines developer Renova Pharmaceuticals LLC announced on Thursday the commercial launch of its first three FDA-approved generic products in the United States: L-Glutamine for Oral Solution, Dimethyl Sulfoxide (DMSO) Irr...